In yesterday’s post, we explored the concept of implied certification under the False Claims Act – a theory which somewhat eliminates the requirement for explicit false claims activity, but requires evidence that the defendant knew or should have known his activity did not comply with a government contract, but continued […]
A defendant may be liable under the False Claims Act on two different theories: the presentment of factually false claims and the presentment of legally false claims. A claim is factually false when a government payee submits information that is untrue on its face and misrepresents the goods or services […]
Aside from healthcare fraud, defense contractor fraud remains one of the top forms of waste and abuse addressed by the False Claims Act. Too often, big-budget defense contracts serve as fodder for dishonest companies to inflate and exaggerate costs, resulting in unnecessary spending of an already-strained defense budget. In one […]
As one of the leading and most successful whistleblower law firms in the United States, Berger Montague is pleased to announce its involvement in a $55.5 million settlement involving three major players in the pharmaceutical industry. This past July, Berger Montague announced the settlement against AstraZeneca, Cephalon, Inc., and BioGen, […]
In yesterday’s post, we introduced an emerging concept known as “balance billing,” which results in skyrocketing medical expenses and increased medical debt for unsuspecting patients. As a brief review, balance billing occurs when a patient seeks treatment from an out-of-network doctor, who then bills the patient for the maximum allowable […]